Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Haschka

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Bone|February 4, 2024
Health-related quality of life and fatigue in adult rare bone disease patients: A cross-sectional study from AustriaMartina Behanova, Amadea Medibach, Judith Haschka, et al.
Nutrients|March 28, 2024
Use of Complementary and Alternative Medicine in Patients with Rare Bone Diseases and OsteoporosisRoland Kocijan, Amadea Medibach, Lisa Lechner, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 13, 2014
Overlapping and continued alendronate or raloxifene administration in patients on teriparatide: effects on areal and volumetric bone mineral density--the CONFORS StudyChristian Muschitz, Roland Kocijan, Astrid Fahrleitner-Pammer, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Diagnosis and management of patients with diabetes and co-existing osteoporosis (Update 2023) : Common guideline of the Austrian Society for Bone and Mineral Research and the Austrian Diabetes Society]Christian Muschitz, Alexandra Kautzky-Willer, Yvonne Winhofer, et al.
Archives of Osteoporosis|March 24, 2026
Digitally enhanced fracture liaison service in Austria-a feasibility analysisAaron Pfender, Martina Behanova, Judith Haschka, et al.
Skeletal Radiology|September 8, 2012
Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfectaRoland Kocijan, Christian Muschitz, Nadja Fratzl-Zelman, et al.
Bone Reports|February 24, 2026
Effects of high-dose methotrexate on bone metabolism: A narrative literature reviewAnton Sokhan, Markus A Hartmann, Stéphane Blouin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2013
Serum sclerostin levels are decreased in adult patients with different types of osteogenesis imperfectaRoland Kocijan, Christian Muschitz, Astrid Fahrleitner-Pammer, et al.
JBMR Plus|September 3, 2024
Longitudinal course of circulating miRNAs in a patient with hypophosphatasia and asfotase alfa treatment: a case reportBenjamin Hadzimuratovic, Judith Haschka, Matthias Hackl, et al.
The Journal of Clinical Endocrinology and Metabolism|November 21, 2022
Circulating miRNAs Respond to Denosumab Treatment After 2 Years in Postmenopausal Women With Osteoporosis-the MiDeTe studyZora Messner, David Carro Vázquez, Judith Haschka, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Bone|February 4, 2024
Health-related quality of life and fatigue in adult rare bone disease patients: A cross-sectional study from AustriaMartina Behanova, Amadea Medibach, Judith Haschka, et al.
Nutrients|March 28, 2024
Use of Complementary and Alternative Medicine in Patients with Rare Bone Diseases and OsteoporosisRoland Kocijan, Amadea Medibach, Lisa Lechner, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 13, 2014
Overlapping and continued alendronate or raloxifene administration in patients on teriparatide: effects on areal and volumetric bone mineral density--the CONFORS StudyChristian Muschitz, Roland Kocijan, Astrid Fahrleitner-Pammer, et al.
Wiener Klinische Wochenschrift|April 26, 2023
[Diagnosis and management of patients with diabetes and co-existing osteoporosis (Update 2023) : Common guideline of the Austrian Society for Bone and Mineral Research and the Austrian Diabetes Society]Christian Muschitz, Alexandra Kautzky-Willer, Yvonne Winhofer, et al.
Archives of Osteoporosis|March 24, 2026
Digitally enhanced fracture liaison service in Austria-a feasibility analysisAaron Pfender, Martina Behanova, Judith Haschka, et al.
Skeletal Radiology|September 8, 2012
Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfectaRoland Kocijan, Christian Muschitz, Nadja Fratzl-Zelman, et al.
Bone Reports|February 24, 2026
Effects of high-dose methotrexate on bone metabolism: A narrative literature reviewAnton Sokhan, Markus A Hartmann, Stéphane Blouin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2013
Serum sclerostin levels are decreased in adult patients with different types of osteogenesis imperfectaRoland Kocijan, Christian Muschitz, Astrid Fahrleitner-Pammer, et al.
JBMR Plus|September 3, 2024
Longitudinal course of circulating miRNAs in a patient with hypophosphatasia and asfotase alfa treatment: a case reportBenjamin Hadzimuratovic, Judith Haschka, Matthias Hackl, et al.
The Journal of Clinical Endocrinology and Metabolism|November 21, 2022
Circulating miRNAs Respond to Denosumab Treatment After 2 Years in Postmenopausal Women With Osteoporosis-the MiDeTe studyZora Messner, David Carro Vázquez, Judith Haschka, et al.
Pageof 7